or
forgot password
  • cancer clinical trials in rochester, MN

  • Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
    Mayo Clinic
    Rochester, Minnesota 55905
    Congenital Myasthenic Syndrome
    Nephrotic Syndrome Study Network
    Mayo Clinic
    Rochester, Minnesota 55905
    Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Magnetic Resonance Elastography (MRE) of Uterine Fibroids
    Mayo Clinic
    Rochester, Minnesota 55905
    Uterine Fibroids
    Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Differential Thyroid Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Multiple Ascending Dose of BMS-911543
    Mayo Clinic
    Rochester, Minnesota 55905
    Cancer
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Mayo Clinic
    Rochester, Minnesota 55905
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
    Mayo Clinic
    Rochester, Minnesota 55905
    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Prostate Cancer
    Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Adult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis, Adult Immunoblastic Large Cell Lymphoma, Adult Lymphoblastic Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3 Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia With Nodal Disease
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    Mayo Clinic
    Rochester, Minnesota 55905
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatosplenic T-cell Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
    Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia
    Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
    Mayo Clinic-Rochester
    Rochester, Minnesota 55905
    Mild Cognitive Impairment
    Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
    Mayo Clinic
    Rochester, Minnesota 55905
    Nonmalignant Breast Conditions, Breast Cancer
    Selecting a Favorable KIR Donor in Unrelated HCT for AML
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Acute Myelogenous Leukemia
    MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
    Mayo Clinic
    Rochester, Minnesota 55905
    Pain, Peripheral Neuropathy
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    Mayo Clinic
    Rochester, Minnesota 55905
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Mayo Clinic - Rochester Mayo - Roch.
    Rochester, Minnesota 55905
    Non-small Cell Lung Cancer
    Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
    Mayo Clinic, Department of Oncology
    Rochester, Minnesota 55901
    Advanced Solid Tumors
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Acute Myeloid Leukemia
    Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Bacterial Infection, Mucositis, Neutropenia
    Safety and Efficacy of Cryoablation for Metastatic Lung Tumors
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Metastatic Lung Cancer
    Clinical Study of PM01183 in Patients With Acute Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Acute Leukemia
    Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
    Mayo Clinic
    Rochester, Minnesota 55905
    Light-Chain Amyloidosis
    Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Estrogen Receptor-positive Breast Cancer, Hot Flashes, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Melanoma, Stage IV Melanoma
    Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Chondrosarcoma, Metastatic Chondrosarcoma
    Use of Tamoxifen in Systemic Mastocytosis
    Mayo Clinic
    Rochester, Minnesota 55905
    Systemic Mastocytosis
    Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma
    Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma
    Mayo Clinic
    Rochester, Minnesota 55905
    Extra-adrenal Paraganglioma, Metastatic Pheochromocytoma, Paraganglioma, Recurrent Pheochromocytoma
    Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Urothelial Carcinoma
    Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database
    Mayo Clinic
    Rochester, Minnesota 55905
    Hematopoietic Stem Cell Transplantation
    Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Malignant Melanoma, Metastatic
    Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage IV Melanoma, Unspecified Adult Solid Tumor, Protocol Specific
    Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy
    Mayo Clinic
    Rochester, Minnesota 55905
    Prostatic Neoplasms, Adenocarcinoma
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Mayo Clinic

    Trial Locations
    Mayo Clinic
    North Central Cancer Treatment Group
    B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Cognitive/Functional Effects, Fatigue, Neurotoxicity, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Therapy-related Toxicity, Waldenström Macroglobulinemia
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    Mayo Clinic
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment